Tech Company Financing Transactions
Rempex Pharmaceuticals Funding Round
Adams Street Partners, Frazier Healthcare Partners and SV Health Investors joined a $20 million funding round for Rempex Pharmaceuticals. The funding round was announced on 3/31/2013.
Transaction Overview
Company Name
Announced On
3/31/2013
Transaction Type
Venture Equity
Amount
$20,000,000
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Acquired or Merged
Industry
Biopharmaceutical
Mailing Address
8 Sylvan Way
Parsippany, NJ 07054
USA
Parsippany, NJ 07054
USA
Phone
Website
Email Address
Overview
Rempex Pharmaceuticals, Inc. is a biopharmaceutical company whose mission is to develop important new therapies to combat the growing issue of antibiotic resistance.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Daniel Burgess
Chief Financial Officer
Eric Loumeau
Chief Medical Officer
Jeffery Loutit
Chief Operating Officer
Jennifer Cayer
Chief Scientific Officer
Michael Dudley
VP - Operations
Elizabeth Morgan
Browse more venture capital transactions:
Prev: 3/31/2013: Unified venture capital transaction
Next: 3/31/2013: Timbre venture capital transaction
Share this article
About Our Venture Capital Transactions Database
We do our best to report on every notable VC transaction. VC investment data records on this site are sourced from publicly available VC deal announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs